Global Cancer Biomarkers Market 2015-2019

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Incidence and Prevalence
08. Biomarkers Used in Cancer Diagnosis
08.1.1 Cancer Biomarkers : FDA Approved till 2012
08.1.2 Cancer Biomarkers : FDA Approved 2013
09. FDA Approval Process for Protein-Based Cancer Biomarkers
10. Geographical Segmentation
10.1 Cancer Biomarkers Market in the Americas
10.1.1 Market Size and Forecast
10.1.2 Cancer Biomarkers Market in US
10.2 Cancer Biomarkers Market in the EMEA Region
10.2.1 Market Size and Forecast
10.3 Cancer Biomarkers Market in APAC Region
10.3.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Vendor Analysis 2014
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Abbott Laboratories
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Segmentation
19.1.4 Business Strategy
19.1.5 Revenue by Business Segmentation
19.1.6 Revenue Comparison 2011 and 2012
19.1.7 Revenue by Geographical Segmentation
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Affymetrix
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation
19.2.4 Business Segmentation by Revenue 2013
19.2.5 Business Segmentation by Revenue 2012 and 2013
19.2.6 Sales by Geography
19.2.7 Business Strategy
19.2.8 Key Information
19.2.9 SWOT Analysis
19.3 Illumina
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation
19.3.4 Geographical Segmentation by Revenue 2013
19.3.5 Business Strategy
19.3.6 Key Information
19.3.7 SWOT Analysis
19.4 Qiagen
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Product Segmentation by Revenue 2013
19.4.4 Product Segmentation by Revenue 2012 and 2013
19.4.5 Geographical Segmentation by Revenue 2013
19.4.6 Business Strategy
19.4.7 Recent Developments
19.4.8 SWOT Analysis
19.5 Quest Diagnostics
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation by Revenue 2013
19.5.4 Business Segmentation by Revenue 2011-2013
19.5.5 Geographical Segmentation by Revenue 2013
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
19.6 Roche Diagnostics
19.6.1 Key Facts
19.6.2 Business Overview
19.6.3 Business Segmentation by Revenue 2013
19.6.4 Geographical Segmentation by Revenue 2013
19.6.5 Business Strategy
19.6.6 Key Developments
19.6.7 SWOT Analysis
20. Other Reports in this Series